McFarland Named NINDS Clinical Director
Dr. Henry McFarland, chief of the NINDS Neuroimmunology Branch, was recently named the institute's clinical director and director of the Clinical Neuroscience Program. He earned his bachelor's degree in 1962 from the University of Arizona and his medical degree in 1966 from the University of Colorado. After completing his clinical training at the Thomas Jefferson Medical College in Philadelphia, he did postdoctoral studies as an NIH special fellow in neurovirology at Johns Hopkins University School of Medicine and in immunology at the University College, London. In 1975, he joined NINDS as deputy chief of the Neuroimmu-nology Branch and was appointed branch chief in 1994. McFarland is a world renowned leader in the field of neuroimmunology, with particular expertise in multiple sclerosis. In addition to his new duties, he will continue to serve as branch chief.
Charland Named CIO at NIGMS
Stacy Charland was recently appointed chief information officer of the National Institute of General Medical Sciences. She will plan and direct all of the institute's information technology efforts. She will also serve as chief of the NIGMS Information Resources Management Branch, overseeing a section covering information and data systems and a section covering personal computer and network technical support. Charland is a database and application design expert who comes to NIGMS from DBA Software, Inc. As president of DBA Software since 1996, she was responsible for company and project management as well as information technology systems development and support at private companies and federal agencies. Prior to working at DBA, she worked at NIGMS as a special expert.
Johnson Appointed to OD Scientific Post
Dr. Alfred C. Johnson has been appointed director of scientific programs and operations, Office of Loan Repayment and Scholarship, Office of the Director. He has been director of the Undergraduate Scholarship Program since January 2000 and will continue as UGSP director in addition to his new responsibilities. He joined NIH as a postdoctoral fellow at the National Cancer Institute in the Laboratory of Molecular Biology under the guidance of Dr. Ira Pastan, and has continued as an investigator there since 1994. His research seeks to understand the regulation of the epidermal growth factor receptor gene, which is found overexpressed in certain cancers. Johnson is a member of the NIH Black Scientists Association, is a member of the NIH Speakers Bureau, and is an instructor in the Bio-Trac series of FAES courses.
Schaefer Named Review Administrator
Dr. Michael Schaefer recently joined the Center for Scientific Review as a scientific review administrator. He will coordinate the review of fellowship applications for the genetic sciences integrated review group this fall before assuming responsibility for the SSS-Y study section. The section evaluates applications for Small Business Innovation Research grants in the areas of genetics, genomics and nucleic acid technology. Schaefer received an M.S. in botany from Iowa State University and a Ph.D. in biochemistry and biophysics from Texas A&M University. His research there focused on light-regulated expression of photosynthesis genes in cyanobacteria, which were the predecessors of higher plant chloroplasts. He continued this research at the Carnegie Institution of Washington in Stanford, Calif., where he received an NIH postdoctoral fellowship. Two years later, he moved to the University of Missouri in Kansas City. He was an assistant professor before becoming an associate professor in its division of molecular biology and biochemistry. Continuing work on cyanobacteria, he identified new molecular components, including a novel DNA-binding protein involved in environmental control of photosynthesis gene expression.
Dombroski Joins CSR
Dr. Alicia Dombroski has become the new scientific review administrator for the microbial physiology and genetics 1 study section at the Center for Scientific Review. She received an M.S. and a Ph.D. in biochemistry from the University of Rochester, where she studied bacterial gene expression and its regulation in E. coli. Her research focused on the Rho protein and its role in transcription and termination. Dombroski continued her studies of E. coli in postdoctoral research at the University of Wisconsin in Madison. During this period, she characterized an RNA polymerase subunit (sigma) and its role in initiating RNA transcription. She then went to the University of Texas Health Science Center in Houston's department of microbiology and molecular genetics. She continued her research on sigma with an NIGMS grant.
Gibson Leads CSR Review Group
Dr. Joyce Gibson recently joined the Center for Scientific Review as chief of the cardiovascular integrated review group, overseeing its eight study sections and related special emphasis panels. She will also serve as the scientific review administrator of the pharmacology study section. Prior to coming to CSR, she was executive director of metabolic and cardiovascular diseases research at Novartis Pharmaceuticals Corp. in New Jersey. She directed multiple efforts to develop treatments for cardiovascular diseases, diabetes, atherosclerosis and lipid disorders. Between 1986 and 1997, she managed the atherosclerosis research program at Novartis' predecessor, Ciba-Geigy Pharmaceuticals. She also conducted postdoc-toral research at Cornell University under a 2-year NIH fellowship.
Up to Top